Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: Analysis of the phase 3 VISION trial.
Michael J MorrisJohann de BonoJames NagarajahOliver SartorXiao X WeiLuke T NordquistVadim S KoshkinKim N ChiBernd J KrauseKen HerrmannKambiz RahbarAdrian VickersOsvaldo MiranteRay GhouseKarim FizaziScott T TagawaPublished in: Cancer (2024)
In this analysis of the VISION study, rPFS correlated strongly with OS but not with time to SSE or worsening HRQOL. These findings require further investigation.